TCRX logo

TScan Therapeutics (TCRX) Revenue

Annual Revenue

$2.82 M
-$18.23 M-86.62%

December 31, 2024


Summary


Performance

TCRX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

Quarterly Revenue

$665.00 K
-$384.00 K-36.61%

December 31, 2024


Summary


Performance

TCRX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$2.82 M
-$6.55 M-69.92%

December 31, 2024


Summary


Performance

TCRX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

TCRX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-86.6%0.0%0.0%
3 y3 years-72.2%0.0%0.0%
5 y5 years-0.0%0.0%

TCRX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-86.6%at low-90.8%+24.1%-86.6%at low
5 y5-year-86.6%+159.5%-90.8%+129.3%-86.6%+871.0%
alltimeall time-86.6%+159.5%-90.8%+129.3%-86.6%+871.0%

TScan Therapeutics Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$2.82 M(-86.6%)
$665.00 K(-36.6%)
$2.82 M(-69.9%)
Sep 2024
-
$1.05 M(+95.7%)
$9.36 M(-23.3%)
Jun 2024
-
$536.00 K(-5.3%)
$12.20 M(-17.6%)
Mar 2024
-
$566.00 K(-92.2%)
$14.81 M(-29.6%)
Dec 2023
$21.05 M(+55.5%)
$7.21 M(+85.5%)
$21.05 M(+24.3%)
Sep 2023
-
$3.89 M(+23.5%)
$16.93 M(+3.2%)
Jun 2023
-
$3.15 M(-53.7%)
$16.41 M(-5.2%)
Mar 2023
-
$6.80 M(+119.8%)
$17.32 M(+27.9%)
Dec 2022
$13.54 M
$3.10 M(-8.0%)
$13.54 M(+1.8%)
DateAnnualQuarterlyTTM
Sep 2022
-
$3.36 M(-17.1%)
$13.29 M(+7.7%)
Jun 2022
-
$4.06 M(+34.3%)
$12.34 M(+10.8%)
Mar 2022
-
$3.02 M(+5.9%)
$11.13 M(+9.8%)
Dec 2021
$10.14 M(+834.7%)
$2.85 M(+18.3%)
$10.14 M(+25.5%)
Sep 2021
-
$2.41 M(-15.3%)
$8.08 M(+35.6%)
Jun 2021
-
$2.85 M(+40.5%)
$5.96 M(+91.5%)
Mar 2021
-
$2.03 M(+155.0%)
$3.11 M(+186.8%)
Dec 2020
$1.08 M
-
-
Dec 2020
-
$795.00 K(+174.1%)
$1.08 M(+274.1%)
Sep 2020
-
$290.00 K
$290.00 K

FAQ

  • What is TScan Therapeutics annual revenue?
  • What is the all time high annual revenue for TScan Therapeutics?
  • What is TScan Therapeutics annual revenue year-on-year change?
  • What is TScan Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for TScan Therapeutics?
  • What is TScan Therapeutics quarterly revenue year-on-year change?
  • What is TScan Therapeutics TTM revenue?
  • What is the all time high TTM revenue for TScan Therapeutics?
  • What is TScan Therapeutics TTM revenue year-on-year change?

What is TScan Therapeutics annual revenue?

The current annual revenue of TCRX is $2.82 M

What is the all time high annual revenue for TScan Therapeutics?

TScan Therapeutics all-time high annual revenue is $21.05 M

What is TScan Therapeutics annual revenue year-on-year change?

Over the past year, TCRX annual revenue has changed by -$18.23 M (-86.62%)

What is TScan Therapeutics quarterly revenue?

The current quarterly revenue of TCRX is $665.00 K

What is the all time high quarterly revenue for TScan Therapeutics?

TScan Therapeutics all-time high quarterly revenue is $7.21 M

What is TScan Therapeutics quarterly revenue year-on-year change?

Over the past year, TCRX quarterly revenue has changed by $0.00 (0.00%)

What is TScan Therapeutics TTM revenue?

The current TTM revenue of TCRX is $2.82 M

What is the all time high TTM revenue for TScan Therapeutics?

TScan Therapeutics all-time high TTM revenue is $21.05 M

What is TScan Therapeutics TTM revenue year-on-year change?

Over the past year, TCRX TTM revenue has changed by $0.00 (0.00%)